Live Updates

25

Mar 2026
Scotiabank says USD/CAD tests mid-1.37 resistance, while the Canadian dollar stays steady, limiting further gains

USD/CAD stayed rangebound near mid-1.37s; oil-supported CAD undervalued, BoC risks watched; resistance mid-1.37, support 1.3690.

25

Mar 2026
AUD/USD drops to about 0.6950 as risk aversion and Middle East tensions boost the US Dollar

AUD/USD neared 0.6950 as Middle East tensions boosted US Dollar demand, while weak Australian PMI pressured.

25

Mar 2026
In March, the US Richmond Fed manufacturing index hit 0, beating forecasts of minus five

Richmond Fed manufacturing index held at 0 in March, beating forecasts of -5, signaling unchanged regional conditions.

25

Mar 2026
US private-sector output expanded moderately, as March’s composite PMI slipped to 51.4, from 51.9

US business activity grew moderately in March; mixed PMIs and Middle East war fueled inflation concerns, dollar rose.

25

Mar 2026
After weaker UK PMI figures, Sterling softens, nudging GBP/JPY down near 212.50 after earlier gains

GBP/JPY edged lower near 212.50 as weak UK PMIs weighed, despite softer Japanese inflation support.

25

Mar 2026
DBS economist says Shin’s stability focus implies no near BoK tightening, making South Korean rate rises unlikely

Yoon nominates Shin as Bank of Korea governor; markets price hikes, but macro risks pressure won, KOSPI.

25

Mar 2026
S&P Global reported US manufacturing PMI at 52.4, beating the 51 forecast during March, rising above expectations

S&P Global’s US Manufacturing PMI rose to 52.4 in March, beating forecasts and signaling manufacturing expansion.

25

Mar 2026
In the United States, March’s S&P Global Services PMI missed forecasts, registering 51.1 versus the expected 51.7

US S&P Global Services PMI in March fell to 51.1, below 51.7 forecast, still signaling expansion.

25

Mar 2026
In March, the US S&P Global Composite PMI fell to 51.4, down from 51.9

S&P Global US Composite PMI slipped to 51.4 in March from 51.9, still indicating expansion.

25

Mar 2026
Vertex Pharmaceuticals, a global biotech, may dip briefly before rising strongly, trading as VRTX on Nasdaq

Vertex Pharmaceuticals (VRTX) shows bullish weekly trend above August 2025 low; break November 2024 high confirms wave (III).

Back To Top
server

Hello there 👋

How can I help you?

We're here to help

Chat with us

Start a live conversation through...

  • Telegram
    hold On hold
  • Coming Soon...

Hello there 👋

How can I help you?

telegram

Our Telegram app is currently under maintenance, we apologize for the inconvenience. For immediate assistance, please contact us via our website live support or by email at [email protected].